Novartis News, Novartis Quote, NVS Quote

Novartis (NY:NVS) Delayed: 156.86 +3.05 (1.98%)

Prev. Close

$153.81

Today 6M 1Y 5Y

Open

$154.15

52 Wk High

$89.15

52 Wk Low

$69.84

Day High

$156.99

Day Low

$154.13

P/E

N/A

EPS

$0.00

Volume

3,734,388

Friends, Peers and Foes (?): NOVN:SW, NOVN, MRK, PFE, RNA (more...)

ALERTS | RSS

Oct 27, 2026 05:26 PM Form SCHEDULE 13G/A NOVARTIS AG Filed by: BlackRock, Inc.
Oct 27, 2026 06:08 AM Form 6-K NOVARTIS AG For: Sep 30
Oct 27, 2026 02:45 AM Novartis (NVS) Tops Q3 EPS by 18c; offers guidance
Oct 26, 2026 05:46 AM UBS Reiterates Neutral Rating on Novartis (NOVN:SW) (NVS)
Oct 26, 2026 05:01 AM Novartis (NOVN:SW) (NVS) PT Lowered to CHF125 at Barclays
Oct 23, 2026 07:46 AM Novartis Kisqali shows survival benefit in early breast cancer trial
Oct 21, 2026 11:03 AM Novartis wins EU approval for Cosentyx in rheumatic disease
Oct 16, 2026 01:37 PM Novartis ends mid-stage trial for Fabhalta in lupus nephritis
Oct 7, 2026 12:48 PM FDA approves Novartis drug Rhapsido for symptomatic dermographism
Oct 7, 2026 07:35 AM Novartis to present MS drug data at MSToronto2026 conference

Entities mentioned with NVS

View All Entities